A. Shelkov

Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates

A. Gintsburg, D. Logunov, B. Naroditsky, 2022, Emerging microbes & infections.

Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus

E. D. Belyaeva, V. Gushchin, I. Grigoriev, 2022, Frontiers in Immunology.

Protocol optimization for obtaining the culture of rat dermal fibroblasts

E.A. Ponomarenko, M.A. Diatroptova, K.A. Artemyeva, 2021, CLINICAL AND EXPERIMENTAL MORPHOLOGY.

Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study

V. Gushchin, A. Gintsburg, D. Logunov, 2023, Frontiers in immunology.

rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19

A. Gintsburg, D. Logunov, B. Naroditsky, 2023, Frontiers in Immunology.

In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1

D. Logunov, A. Siniavin, I. Dolzhikova, 2023, Vaccines.